Good Samaritan Regional Medical Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1913-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 4:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (66.7%)Not Applicable
1 (33.3%)Evaluating the Impact of Ambient AI on Documentation Efficiency and Clinician Burnout in Primary Care Settings
Not Applicable
Completed
- Conditions
- BurnoutClinical Documentation Efficiency
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2024-09-20
- Lead Sponsor
- Samaritan Health Services
- Target Recruit Count
- 45
- Registration Number
- NCT06605976
- Locations
- 🇺🇸
Samaritan Health Services, Corvallis, Oregon, United States
Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection
Phase 4
- Conditions
- Benign Neoplasm
- Interventions
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Samaritan Health Services
- Target Recruit Count
- 140
- Registration Number
- NCT05082441
- Locations
- 🇺🇸
Good Samaritan Regional Medical Center, Corvallis, Oregon, United States
GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2020-12-04
- Lead Sponsor
- Samaritan Health Services
- Target Recruit Count
- 10
- Registration Number
- NCT04473274
- Locations
- 🇺🇸
Good Samaritan Hospital Corvallis, Corvallis, Oregon, United States
News
No news found